Warenkorb
 

The Evidence, However, Is Clear: The Seroxat Scandal

Bob Fiddaman was prescribed Seroxat due to depression that was, in essence, due to work related problems.

What followed was a journey that took him through a tapering process of, what he believes to be, a highly addictive antidepressant.

Following almost two years of withdrawal, Fiddaman's new battle with the manufacturer of the drug, GlaxoSmithKline and the UK's medicine regulator, the MHRA, took him on a more frustrating journey than he ever could have imagined.

The name Bob Fiddaman has become synonymous throughout cyberspace. Google his name and you will find articles he has written, many of which have been republished by a vast army of fellow patient advocates.

In his debut book, Fiddaman takes the bull by the horns and pulls no punches.

Doctor's and patients alike will find Fiddaman's journey both tragic and informative, in particular the current stance of the UK regulator with regard to pregnancy and antidepressants.

It may also make you stop and seriously reconsider the safety and efficacy of the medications you take.

… weiterlesen
In den Warenkorb

Beschreibung

Produktdetails


Einband Taschenbuch
Seitenzahl 184
Erscheinungsdatum März 2011
Sprache Englisch
ISBN 978-1-84991-414-7
Verlag Chipmunka Publishing
Maße (L/B/H) 20,3/12,7/1,1 cm
Gewicht 204 g
Buch (Taschenbuch, Englisch)
18,99
inkl. gesetzl. MwSt.
Versandfertig in 1 - 2 Wochen
Versandkostenfrei
In den Warenkorb
PAYBACK Punkte
Ihr Feedback zur Seite
Haben Sie alle relevanten Informationen erhalten?
Vielen Dank für Ihr Feedback!
Entschuldigung, beim Absenden Ihres Feedbacks ist ein Fehler passiert. Bitte versuchen Sie es erneut.

Kundenbewertungen

Es wurden noch keine Bewertungen geschrieben.